HEADER HYDROLASE 28-AUG-06 2I67 TITLE STRUCTURAL BASIS FOR THE MECHANISTIC UNDERSTANDING HUMAN CD38 TITLE 2 CONTROLLED MULTIPLE CATALYSIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYCLIC ADP-RIBOSE HYDROLASE 1, CADPR HYDROLASE 1, LYMPHOCYTE COMPND 5 DIFFERENTIATION ANTIGEN CD38, T10, ACUTE LYMPHOBLASTIC LEUKEMIA CELLS COMPND 6 ANTIGEN CD38; COMPND 7 EC: 3.2.2.5; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD38; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: X-33; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPICZAA KEYWDS THE CATALYTIC POCKET, REACTION PRODUCT, REACTION INTERMEDIATE, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Q.LIU,I.A.KRIKSUNOV,R.GRAEFF,C.MUNSHI,H.C.LEE,Q.HAO REVDAT 5 30-AUG-23 2I67 1 REMARK REVDAT 4 20-OCT-21 2I67 1 REMARK SEQADV REVDAT 3 24-FEB-09 2I67 1 VERSN REVDAT 2 21-NOV-06 2I67 1 JRNL REVDAT 1 05-SEP-06 2I67 0 JRNL AUTH Q.LIU,I.A.KRIKSUNOV,R.GRAEFF,C.MUNSHI,H.C.LEE,Q.HAO JRNL TITL STRUCTURAL BASIS FOR THE MECHANISTIC UNDERSTANDING OF HUMAN JRNL TITL 2 CD38-CONTROLLED MULTIPLE CATALYSIS. JRNL REF J.BIOL.CHEM. V. 281 32861 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16951430 JRNL DOI 10.1074/JBC.M606365200 REMARK 2 REMARK 2 RESOLUTION. 1.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 3 NUMBER OF REFLECTIONS : 49477 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2665 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.71 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2406 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.50 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 134 REMARK 3 BIN FREE R VALUE : 0.2830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3995 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 471 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.80000 REMARK 3 B22 (A**2) : 0.96000 REMARK 3 B33 (A**2) : 0.63000 REMARK 3 B12 (A**2) : 0.46000 REMARK 3 B13 (A**2) : 0.52000 REMARK 3 B23 (A**2) : 0.97000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.128 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.127 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.082 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.809 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4223 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5744 ; 1.626 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 498 ; 5.997 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 194 ;37.063 ;24.021 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 710 ;16.303 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;20.094 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 615 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3151 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1981 ; 0.229 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2811 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 349 ; 0.179 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 84 ; 0.269 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 27 ; 0.203 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2551 ; 1.039 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4024 ; 1.691 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1943 ; 2.725 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1720 ; 3.902 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2I67 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039187. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52170 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.300 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YH3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, 12% PEG 4000, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE TWO BIOLOGICAL UNITS IN THE CRYSTALLOGRAPHIC REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 39 REMARK 465 ARG A 40 REMARK 465 GLU A 41 REMARK 465 ALA A 42 REMARK 465 GLU A 43 REMARK 465 ALA A 44 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 465 LYS B 39 REMARK 465 ARG B 40 REMARK 465 GLU B 41 REMARK 465 ALA B 42 REMARK 465 GLU B 43 REMARK 465 ALA B 44 REMARK 465 ASP B 293 REMARK 465 SER B 294 REMARK 465 SER B 295 REMARK 465 CYS B 296 REMARK 465 THR B 297 REMARK 465 SER B 298 REMARK 465 GLU B 299 REMARK 465 ILE B 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 247 CB CG CD NE CZ NH1 NH2 REMARK 470 GLU A 248 CB CG CD OE1 OE2 REMARK 470 ASP A 249 CB CG OD1 OD2 REMARK 470 ARG A 280 CB CG CD NE CZ NH1 NH2 REMARK 470 ASN A 290 CG OD1 ND2 REMARK 470 PRO A 291 CB CG CD REMARK 470 GLU A 292 CB CG CD OE1 OE2 REMARK 470 ASP A 293 CB CG OD1 OD2 REMARK 470 SER A 294 CB OG REMARK 470 SER A 295 CB OG REMARK 470 ARG B 247 CB CG CD NE CZ NH1 NH2 REMARK 470 GLU B 248 CB CG CD OE1 OE2 REMARK 470 ASP B 249 CB CG OD1 OD2 REMARK 470 SER B 250 CB OG REMARK 470 ARG B 280 CB CG CD NE CZ NH1 NH2 REMARK 470 ASN B 290 CB CG OD1 ND2 REMARK 470 PRO B 291 CB CG CD REMARK 470 GLU B 292 CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 72 CD GLU A 72 OE2 0.076 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 48 146.18 54.80 REMARK 500 ASP A 202 -123.56 59.70 REMARK 500 SER A 213 -49.70 124.35 REMARK 500 ARG A 247 -74.83 61.31 REMARK 500 GLU A 248 -83.11 140.77 REMARK 500 GLU A 292 155.22 72.73 REMARK 500 ASP A 293 113.02 95.30 REMARK 500 ILE B 128 43.15 -149.58 REMARK 500 ASP B 179 -79.22 -108.53 REMARK 500 ASP B 202 -125.52 58.13 REMARK 500 SER B 213 -60.58 59.03 REMARK 500 HIS B 244 -166.90 -73.90 REMARK 500 ARG B 247 -46.25 53.83 REMARK 500 GLU B 248 -128.51 -133.78 REMARK 500 ASP B 249 76.91 69.88 REMARK 500 SER B 250 30.86 -93.90 REMARK 500 ASN B 290 68.83 -101.93 REMARK 500 PRO B 291 137.39 -31.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE APR A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE APR B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE APR B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I65 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE MECHANISTIC UNDERSTANDING HUMAN CD38 REMARK 900 CONTROLLED MULTIPLE CATALYSIS REMARK 900 RELATED ID: 2I66 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE MECHANISTIC UNDERSTANDING HUMAN CD38 REMARK 900 CONTROLLED MULTIPLE CATALYSIS DBREF 2I67 A 45 300 UNP P28907 CD38_HUMAN 45 300 DBREF 2I67 B 45 300 UNP P28907 CD38_HUMAN 45 300 SEQADV 2I67 LYS A 39 UNP P28907 CLONING ARTIFACT SEQADV 2I67 ARG A 40 UNP P28907 CLONING ARTIFACT SEQADV 2I67 GLU A 41 UNP P28907 CLONING ARTIFACT SEQADV 2I67 ALA A 42 UNP P28907 CLONING ARTIFACT SEQADV 2I67 GLU A 43 UNP P28907 CLONING ARTIFACT SEQADV 2I67 ALA A 44 UNP P28907 CLONING ARTIFACT SEQADV 2I67 THR A 49 UNP P28907 GLN 49 ENGINEERED MUTATION SEQADV 2I67 ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 2I67 ASP A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 2I67 ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 2I67 ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 2I67 LYS B 39 UNP P28907 CLONING ARTIFACT SEQADV 2I67 ARG B 40 UNP P28907 CLONING ARTIFACT SEQADV 2I67 GLU B 41 UNP P28907 CLONING ARTIFACT SEQADV 2I67 ALA B 42 UNP P28907 CLONING ARTIFACT SEQADV 2I67 GLU B 43 UNP P28907 CLONING ARTIFACT SEQADV 2I67 ALA B 44 UNP P28907 CLONING ARTIFACT SEQADV 2I67 THR B 49 UNP P28907 GLN 49 ENGINEERED MUTATION SEQADV 2I67 ASP B 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 2I67 ASP B 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 2I67 ASP B 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 2I67 ASP B 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQRES 1 A 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 A 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 A 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 A 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 A 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 A 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 A 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 A 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 A 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 A 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 A 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 A 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 A 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 A 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 A 262 THR PHE GLY SER VAL GLU VAL HIS ASN LEU GLN PRO GLU SEQRES 16 A 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 A 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 A 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 A 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 A 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 A 262 GLU ILE SEQRES 1 B 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 B 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 B 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 B 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 B 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 B 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 B 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 B 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 B 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 B 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 B 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 B 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 B 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 B 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 B 262 THR PHE GLY SER VAL GLU VAL HIS ASN LEU GLN PRO GLU SEQRES 16 B 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 B 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 B 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 B 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 B 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 B 262 GLU ILE HET APR A 301 36 HET APR B 301 36 HET APR B 302 36 HETNAM APR ADENOSINE-5-DIPHOSPHORIBOSE FORMUL 3 APR 3(C15 H23 N5 O14 P2) FORMUL 6 HOH *471(H2 O) HELIX 1 1 ARG A 58 HIS A 74 1 17 HELIX 2 2 PRO A 75 VAL A 80 5 6 HELIX 3 3 ASP A 81 ALA A 92 1 12 HELIX 4 4 THR A 102 ASP A 105 5 4 HELIX 5 5 TYR A 106 GLY A 113 1 8 HELIX 6 6 ILE A 128 GLN A 139 1 12 HELIX 7 7 THR A 144 ASP A 147 5 4 HELIX 8 8 THR A 148 ASP A 155 1 8 HELIX 9 9 ASN A 183 ALA A 200 1 18 HELIX 10 10 SER A 220 VAL A 225 1 6 HELIX 11 11 GLU A 226 LEU A 230 5 5 HELIX 12 12 ASP A 252 GLN A 255 5 4 HELIX 13 13 ASP A 256 ARG A 269 1 14 HELIX 14 14 ARG A 280 ASN A 290 1 11 HELIX 15 15 ARG B 58 HIS B 74 1 17 HELIX 16 16 PRO B 75 ARG B 78 5 4 HELIX 17 17 ASP B 81 ILE B 94 1 14 HELIX 18 18 THR B 102 ASP B 105 5 4 HELIX 19 19 TYR B 106 GLY B 113 1 8 HELIX 20 20 ILE B 128 GLN B 137 1 10 HELIX 21 21 THR B 144 ASP B 147 5 4 HELIX 22 22 THR B 148 ASP B 155 1 8 HELIX 23 23 ASN B 183 ALA B 199 1 17 HELIX 24 24 SER B 220 VAL B 225 1 6 HELIX 25 25 GLU B 226 LEU B 230 5 5 HELIX 26 26 ASP B 252 GLN B 255 5 4 HELIX 27 27 ASP B 256 ARG B 269 1 14 HELIX 28 28 ARG B 280 ASN B 290 1 11 SHEET 1 A 2 GLY A 52 PRO A 53 0 SHEET 2 A 2 SER A 172 CYS A 173 -1 O CYS A 173 N GLY A 52 SHEET 1 B 4 LEU A 123 SER A 126 0 SHEET 2 B 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 B 4 VAL A 235 ILE A 243 1 O TRP A 241 N VAL A 206 SHEET 4 B 4 GLN A 272 ILE A 278 1 O ILE A 278 N VAL A 242 SHEET 1 C 2 GLY B 52 PRO B 53 0 SHEET 2 C 2 SER B 172 CYS B 173 -1 O CYS B 173 N GLY B 52 SHEET 1 D 4 LEU B 123 SER B 126 0 SHEET 2 D 4 ASP B 202 ASP B 209 1 O HIS B 205 N LEU B 124 SHEET 3 D 4 VAL B 235 ILE B 243 1 O THR B 237 N VAL B 204 SHEET 4 D 4 GLN B 272 ILE B 278 1 O LYS B 276 N VAL B 242 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.09 SSBOND 2 CYS A 99 CYS A 180 1555 1555 2.11 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.04 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.13 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.15 SSBOND 6 CYS A 287 CYS A 296 1555 1555 2.03 SSBOND 7 CYS B 67 CYS B 82 1555 1555 2.08 SSBOND 8 CYS B 99 CYS B 180 1555 1555 2.10 SSBOND 9 CYS B 119 CYS B 201 1555 1555 2.05 SSBOND 10 CYS B 160 CYS B 173 1555 1555 2.14 SSBOND 11 CYS B 254 CYS B 275 1555 1555 2.05 SITE 1 AC1 14 TRP A 125 SER A 126 ARG A 127 LEU A 145 SITE 2 AC1 14 GLU A 146 TRP A 189 SER A 193 SER A 220 SITE 3 AC1 14 THR A 221 PHE A 222 GLU A 226 HOH A 342 SITE 4 AC1 14 HOH A 360 HOH A 411 SITE 1 AC2 18 TRP B 125 SER B 126 ARG B 127 LEU B 145 SITE 2 AC2 18 GLU B 146 ARG B 177 SER B 193 ASP B 217 SITE 3 AC2 18 ASP B 219 SER B 220 THR B 221 PHE B 222 SITE 4 AC2 18 GLU B 226 APR B 302 HOH B 330 HOH B 361 SITE 5 AC2 18 HOH B 384 HOH B 434 SITE 1 AC3 10 TRP B 125 LYS B 129 GLU B 146 ASP B 155 SITE 2 AC3 10 ASP B 156 TRP B 189 ARG B 212 APR B 301 SITE 3 AC3 10 HOH B 316 HOH B 434 CRYST1 41.893 51.152 65.639 109.36 91.22 97.38 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023870 0.003093 0.001649 0.00000 SCALE2 0.000000 0.019713 0.007057 0.00000 SCALE3 0.000000 0.000000 0.016185 0.00000